Worldwide Cancer Research Menu

Developing a new approach to targeting lung cancers

  • Researcher: Dr Silvestre Vicent
  • Institution: FFPIMA, Pamplona, Spain
  • Award Amount: £139,060 from January 2016 for 3 years
  • Cancer Type: Lung Cancer
Developing a new approach to targeting lung cancers
Dr Silvestre Vicent is working hard to develop a new approach to targeting lung cancers with mutations in a gene called KRAS.

Worldwide, nearly 1.83 million new cases of lung cancer were estimated to have been diagnosed in 2012 and it is the leading cause of death from cancer in Europe. Non-small cell lung cancer (NSCLC) is the most common type and represents about 80% of total lung cancers. In these NSCLC tumours, KRAS is the most commonly mutated cancer-causing gene (oncogene), found in over 20% of patients."

Dr Vicent told us “Since KRAS mutations are directly responsible for NSCLC, KRAS represents an ideal target to try and turn off in order to prevent NSCLC development. Yet, efforts to develop therapeutic inhibitors against KRAS have failed for over 20 years. Thus, it is critical to identify targets of oncogenic KRAS that could unveil new therapeutic candidates.

A previous search for molecules downstream of activated KRAS led to the identification of a series of up-regulated ‘microRNAs’. MicroRNAs (miRNAs) regulate expression of key genes in normal and cancerous cells. We hypothesize that these microRNAs play a key role in cells harboring KRAS mutations.”

He added “The goal of this work is to carry out proof-of-concept testing on the role of the miRNAs afected by activated KRAS. We expect to identify miRNA target genes involved in cancer development driven by KRAS. Eventually we hope to apply these findings to develop new therapeutic strategies targeting KRAS in NSCLC patients.”

He concluded "This grant from Worldwide Cancer Research is of paramount importance to consolidate our research group and increase its visibility to the scientific community.”

The project is an excellent opportunity to test whether KRAS-regulated miRNAs represent functionally relevant targets for which novel therapeutic strategies could be eventually developed".

Showing: All projects

The Research That Is Happening Right Now

Explore current projects to see how far-reaching our research is from a global perspective.

Projects per page: 31020

Our Impact

See the difference our research projects make.

Philosophy
Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...
Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....
Read more